Although genetic background was reported to affect the prevalence of prostate cancer [39], we found, however, that it has minimal effect on the formation of prostate tumor, if Deptor is deleted in combination with heterozygous Pten loss. The gene discussed is DEPTOR; the disease is prostate carcinoma.